IP Verse

Von Seebach competitive analysis

Loading summary...

Explore patent oppositions filed by Von Seebach against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3453387	Dosage Regimen For A S1P Receptor Agonist	NOVARTIS	Mar 3, 2021
EP3409274	Dosage Regimen For A S1P Receptor Agonist	NOVARTIS	Aug 18, 2020
EP3246021	Apixaban Formulations	BRISTOL MYERS SQUIBB IRELAND	Aug 6, 2020

Explore the latest publications and patents granted to Von Seebach, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Von Seebach, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Von Seebach with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
VON SEEBACH	3	-	-	-
BRISTOL MYERS SQUIBB IRELAND	-	43	-	-
BRISTOL MYERS SQUIBB IRELAND UNLIMITED	-	43	-	-
NOVARTIS	6	422	-	21